prnewswire.com/news-release...
Annovis will be making two presentations at the upcoming AD/PD™ 2023 International Conference on Alzheimer's and Parkinson's Disease, which is taking place from March 28 through April 1, 2023, in Gothenburg, Sweden.
The first presentation will discuss the Company's development plan for Parkinson's (PD) and Alzheimer's disease (AD), and the second presentation will show how mouse data fully predicts human outcome in improving function in AD and PD.
Periodontal (Gum) Disease 
Thumbs up for Nilotinib - Phase II Trials
Presentation from Dr. Thomas Guttuso, Lithium for PD
Vitamin D supplementation worsens Alzheimer's progression: Animal model and human cohort studies 2022
Dr Espay - The missing ingredient for successful disease modification in PD - Recording available
